IP Verse

Sandoz Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Sandoz Gmbh

Patent Number:
EP3346995
Title:
Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus
Applicant:
GILEAD SCIENCES, INC.
Opposition Date:
May 28, 2020
Patent Number:
EP2188302
Title:
Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides
Applicant:
GENENTECH, INC.
Opposition Date:
Jan 22, 2020
Patent Number:
EP2252148
Title:
Methods For Treating Bowel Diseases
Applicant:
SALIX PHARMACEUTICALS, INC.
Opposition Date:
Dec 18, 2019
Patent Number:
EP2618819
Title:
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
Applicant:
ALFASIGMA S.P.A.
Opposition Date:
Jul 31, 2018
Patent Number:
EP2059232
Title:
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin
Applicant:
ALFASIGMA S.P.A.
Opposition Date:
Jan 19, 2018

Competitors of Sandoz Gmbh

ALFASIGMA S.P.A.

ALFA WASSERMANN S.P.A.

GENENTECH, INC.

Want to track Sandoz Gmbh?

Feel free to send us a message here and we will get back to you